Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75752917 | 7575291 | 7 | F | 20070919 | 20160222 | 20100907 | 20160722 | EXP | GB-BRISTOL-MYERS SQUIBB COMPANY-15268303 | BRISTOL MYERS SQUIBB | 19.00 | YR | F | Y | 0.00000 | 20160722 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75752917 | 7575291 | 1 | PS | ETOPOPHOS | ETOPOSIDE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 4650 MG, QD | U | 20457 | 4650 | MG | SOLUTION FOR INJECTION/INFUSION | QD | |||||
| 75752917 | 7575291 | 2 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | SOLUTION FOR INFUSION | ||||||||
| 75752917 | 7575291 | 3 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Intravenous (not otherwise specified) | INF | U | 0 | CAPSULE, HARD | ||||||||
| 75752917 | 7575291 | 4 | SS | ACICLOVIR | ACYCLOVIR | 1 | Unknown | U | 0 | ||||||||||
| 75752917 | 7575291 | 5 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 75752917 | 7575291 | 6 | SS | CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | 1 | Intravenous (not otherwise specified) | 70 MG, QD | U | 0 | 70 | MG | QD | ||||||
| 75752917 | 7575291 | 7 | SS | CHLORPHENAMINE | CHLORPHENIRAMINE MALEATE | 1 | Intravenous (not otherwise specified) | 10 MG, QID | U | 0 | 10 | MG | QID | ||||||
| 75752917 | 7575291 | 8 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | 0 | |||||||||||
| 75752917 | 7575291 | 9 | SS | KETALAR | KETAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 6 ML, QH | N | 0 | 6 | ML | /hr | ||||||
| 75752917 | 7575291 | 10 | SS | NORETHISTERONE | NORETHINDRONE | 1 | Oral | 5 MG, TID | U | 0 | 5 | MG | TID | ||||||
| 75752917 | 7575291 | 11 | SS | OMEPRAZOL E | OMEPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 75752917 | 7575291 | 12 | SS | ONDANSETRON | ONDANSETRON | 1 | Intravenous (not otherwise specified) | ALSO TAKEN 6 MG OD | U | 0 | 8 | MG | TID | ||||||
| 75752917 | 7575291 | 13 | SS | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 4.5 MG, TID | U | 0 | 4.5 | MG | TID | ||||||
| 75752917 | 7575291 | 14 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | Oral | 200 MG, BID | U | 0 | 200 | MG | BID | ||||||
| 75752917 | 7575291 | 15 | C | TPN | AMINO ACIDSDEXTROSEELECTROLYTES NOSSOYBEAN OIL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 75752917 | 7575291 | 1 | Product used for unknown indication |
| 75752917 | 7575291 | 2 | Product used for unknown indication |
| 75752917 | 7575291 | 3 | Product used for unknown indication |
| 75752917 | 7575291 | 4 | Product used for unknown indication |
| 75752917 | 7575291 | 5 | Product used for unknown indication |
| 75752917 | 7575291 | 6 | Product used for unknown indication |
| 75752917 | 7575291 | 7 | Product used for unknown indication |
| 75752917 | 7575291 | 8 | Product used for unknown indication |
| 75752917 | 7575291 | 9 | Mucosal pain |
| 75752917 | 7575291 | 10 | Product used for unknown indication |
| 75752917 | 7575291 | 11 | Product used for unknown indication |
| 75752917 | 7575291 | 12 | Product used for unknown indication |
| 75752917 | 7575291 | 13 | Product used for unknown indication |
| 75752917 | 7575291 | 14 | Product used for unknown indication |
| 75752917 | 7575291 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 75752917 | 7575291 | LT |
| 75752917 | 7575291 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 75752917 | 7575291 | Dilatation intrahepatic duct acquired | |
| 75752917 | 7575291 | Hepatotoxicity | |
| 75752917 | 7575291 | Off label use | |
| 75752917 | 7575291 | Venoocclusive liver disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 75752917 | 7575291 | 1 | 20070915 | 20070915 | 0 | |
| 75752917 | 7575291 | 9 | 20070921 | 20070928 | 0 |